Welcome to EQUITY DEVELOPMENT
The UK's longest established regulated provider of sponsored equity research.
We launched EQUITY DEVELOPMENT in 1997 becoming the first ever regulated provider of Sponsored Equity Research in the UK.
Our research teams are made up of expert analysts with deep understanding & experience in their sectors. Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).
We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.
Search for Company Research
FREE REGISTRATION
Sign up today and access the very latest company research
LOG IN
For access to all company research please
Genosis
Genosis PLC (GNOS) is a medical device company that develops and commercialises innovative, proprietary point-of-care OTC diagnostics products for human reproductive health.
US orders show potential
- Genosis provides the only FDA cleared OTC fertility test for couples
- First two US orders for Fertell combination packs
- £2.3m being raised for US marketing spend
- Female only tests sales begin in UK
Publication Date:
May 29 2007